The Netherlands Chlamydia Cohort Study

The Netherlands Chlamydia Cohort Study: assessing the risk of late complications after Chlamydia trachomatis infection in women

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON23749

Enrollment

14685

Registered

2015-12-18

Start date

2015-10-26

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genital Chlamydia trachomatis infection Pelvic Inflammatory Disease (PID) Ectopic pregnancy (Tubal) infertility Prolonged time to pregnancy Genitale Chlamydia trachomatis infectie PID Ectopische zwangerschap Tubaire infertiliteit Verlengde duur tot zwangerschap

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: - Being a women; - Participated in at least one round of the Chlamydia Screening Implementation between 2008 and 2011; - Given informed consent in the Chlamydia Screening Implementation to be contacted again for future STI-related research.

Exclusion criteria

Exclusion criteria: - Not living in the Netherlands anymore; - No traceable address information.

Design outcomes

Primary

Measure	Time frame
The main outcomes of the study are Pelvic Inflammatory Disease (PID), ectopic pregnancy, tubal infertility and time to pregnancy. The primary study parameter is the presence of a previous Chlamydia trachomatis infection.	—

Secondary

Measure	Time frame
The secondary study parameters include candidate host genetic biomarkers (SNPs) and behavioural, demographic, and pathogen factors possibly associated with the development of Chlamydia trachomatis related complications.	—

Contacts

Public ContactBernice Hoenderboom

Postbus 1

bernice.hoenderboom@rivm.nl+31302744766

Outcome results